Write in a clean editor, then format for Therapeutic Advances in Psychopharmacology in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Therapeutic Advances in Psychopharmacology is a peer-reviewed journal published by SAGE, covering Schizophrenia research and treatment, Treatment of Major Depression, Bipolar Disorder and Treatment.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Therapeutic Advances in Psychopharmacology, 12(3), pp. 45–58.
Formats any DOI in Therapeutic Advances in Psychopharmacology style. No sign-up. |
| Publishes research in | Schizophrenia research and treatment Treatment of Major Depression Bipolar Disorder and Treatment Tryptophan and brain disorders Electroconvulsive Therapy Studies |
| ISSN | 2045-1253 |
| Citation impact (2-yr) | 2.33 |
| h-index | 61 |
| i10-index | 319 |
| Total citations | 16,139 |
| Article processing charge | $2,300 |
| Open access | Yes |
| Top institutions publishing here | King's College London |
| Journal website | us.sagepub.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Cannabis is a complex plant, with major compounds such as delta-9-tetrahydrocannabinol and cannabidiol, which have opposing effects. The discovery of its compounds has led to the further discovery of an important neurotransmitter system called the endocannabinoid system. This system is widely distributed in the brain and in the body, and is considered to be responsible…
Bipolar disorder is a multifactorial illness with uncertain aetiology. Knowledge of potential risk factors enables clinicians to identify patients who are more likely to develop bipolar disorder, which directs further investigation, follow up and caution when prescribing. Ideally, identifying directly causative factors for bipolar disorder would enable intervention on an individual or population level to…
New psychoactive substances (NPS) are a heterogeneous group of substances. They are associated with a number of health and social harms on an individual and societal level. NPS toxicity and dependence syndromes are recognised in primary care, emergency departments, psychiatric inpatient and community care settings. One pragmatic classification system is to divide NPS into one…
Despite their widespread use, long-acting injectable (LAI) antipsychotics (APs) are often regarded with some negativity because of the assumption of punishment, control and insufficient evolution towards psychosocial development of patients. However, LAI APs have proved effective in schizophrenia and other severe psychotic disorders because they assure stable blood levels, leading to a reduction of the…
Schizophrenia is the eighth leading cause of disability worldwide in people aged 15–44 years. Before antidopaminergic antipsychotics were introduced in the 1950s, no effective medications existed for the treatment of schizophrenia. This review summarizes key meta-analytic findings regarding antipsychotic efficacy in the acute treatment of schizophrenia, including clozapine in treatment-resistant patients. In the most comprehensive…
Proceedings of the Institution of Mechanical Engineers, Part C: Journal of Mechanical Engineering Science
Progress in Human Geography
Qualitative Health Research
Sage Open Medicine
Social Psychological and Personality Science
Sports Health: A Multidisciplinary Approach
The American Review of Public Administration
Theoretical Criminology
